Loading...

Grody Wayne

TitleProfessor
InstitutionUniversity of California Los Angeles
DepartmentPathology and Laboratory Medicine
Address200 UCLA Med Plaza Suite 265
Los Angeles CA 90095
Phone(310) 825-5648
vCardDownload vCard
    Other Positions
    TitleProfessor

    TitleProfessor

    TitleDirector

    TitleChief

    TitleChief


    Collapse Research 
    Collapse Research Activities and Funding
    CYSTIC FIBROSIS MUTATION SCREENING AND COUNSELING
    NIH/NICHD R01HD029337Sep 30, 1991 - Aug 31, 1995
    Role: Principal Investigator
    GENE TRANSFER OF HUMAN ARGINASE
    NIH/NICHD K08HD000831Feb 1, 1988 - Jan 31, 1991
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Datkhaeva I, Arboleda VA, Senaratne TN, Nikpour G, Meyerson C, Geng Y, Afshar Y, Scibetta E, Goldstein J, Quintero-Rivera F, Crandall BF, Grody WW, Deignan J, Janzen C. Identification of novel PIEZO1 variants using prenatal exome sequencing and correlation to ultrasound and autopsy findings of recurrent hydrops fetalis. Am J Med Genet A. 2018 Sep 23. PMID: 30244526.
      View in: PubMed
    2. Kansal R, Grody WW, Zhou J, Dong L, Li X. The Value of T-Cell Receptor ? (TRG) Clonality Evaluation by Next-Generation Sequencing in Clinical Hematolymphoid Tissues: A Descriptive Study of 41 Cases From a Single Institution. Am J Clin Pathol. 2018 Jul 05. PMID: 29982316.
      View in: PubMed
    3. Richards CS, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL. Response to Biesecker and Harrison. Genet Med. 2018 Mar 15. PMID: 29543230.
      View in: PubMed
    4. Mullegama SV, Klein SD, Nguyen DC, Kim A, Signer R, Fox M, Dorrani N, Hendershot A, Mardach R, Suddath R, Dipple K, Vilain E, Wong DA, Deignan JL, D Cederbaum S, Grody WW, Martinez-Agosto JA. Is it time to retire fragile X testing as a first-tier test for developmental delay, intellectual disability, and autism spectrum disorder? Genet Med. 2017 Dec; 19(12). PMID: 28933790.
      View in: PubMed
    5. Kaul KL, Sabatini LM, Tsongalis GJ, Caliendo AM, Olsen RJ, Ashwood ER, Bale S, Benirschke R, Carlow D, Funke BH, Grody WW, Hayden RT, Hegde M, Lyon E, Murata K, Pessin M, Press RD, Thomson RB. The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care. Acad Pathol. 2017 Jan-Dec; 4:2374289517708309. PMID: 28815200.
      View in: PubMed
    6. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG. CORRIGENDUM: ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2017 05; 19(5):606. PMID: 28492529.
      View in: PubMed
    7. Mullegama SV, Jensik P, Li C, Dorrani N, Kantarci S, Blumberg B, Grody WW, Strom SP. Coupling clinical exome sequencing with functional characterization studies to diagnose a patient with familial Mediterranean fever and MED13L haploinsufficiency syndromes. Clin Case Rep. 2017 Jun; 5(6):833-840. PMID: 28588821.
      View in: PubMed
    8. Allyse M, Aypar U, Bonhomme N, Darilek S, Dougherty M, Farrell R, Grody W, Highsmith WE, Michie M, Nunes M, Otto L, Pabst R, Palomaki G, Runke C, Sharp RR, Skotko B, Stoll K, Wick M. Offering Prenatal Screening in the Age of Genomic Medicine: A Practical Guide. J Womens Health (Larchmt). 2017 Jul; 26(7):755-761. PMID: 28388340.
      View in: PubMed
    9. Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. J Oncol Pract. 2017 May; 13(5):333-337. PMID: 28350513.
      View in: PubMed
    10. Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. J Mol Diagn. 2017 03; 19(2):187-225. PMID: 28185757.
      View in: PubMed
    11. Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Bryan Rumble R, Temple-Smolkin R, B Ventura C, Nowak JA. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. Arch Pathol Lab Med. 2017 May; 141(5):625-657. PMID: 28165284.
      View in: PubMed
    12. Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology. J Clin Oncol. 2017 May 01; 35(13):1453-1486. PMID: 28165299.
      View in: PubMed
    13. Sepulveda AR, Hamilton SR, Allegra CJ, Grody W, Cushman-Vokoun AM, Funkhouser WK, Kopetz SE, Lieu C, Lindor NM, Minsky BD, Monzon FA, Sargent DJ, Singh VM, Willis J, Clark J, Colasacco C, Rumble RB, Temple-Smolkin R, Ventura CB, Nowak JA. Molecular Biomarkers for the Evaluation of Colorectal Cancer. Am J Clin Pathol. 2017 Feb 03. PMID: 28165529.
      View in: PubMed
    14. Grody WW. Prenatal Carrier Screening-Reply. JAMA. 2016 12 27; 316(24):2676-2677. PMID: 28027361.
      View in: PubMed
    15. Benhammou JN, Phan J, Lee H, Ghassemi K, Parsons W, Grody WW, Pisegna JR. A Sodium Channel Myotonia Presenting with Intermittent Dysphagia as a Manifestation of a Rare SCN4A Variant. J Mol Neurosci. 2017 Mar; 61(3):312-314. PMID: 28012096.
      View in: PubMed
    16. Ge X, Gong H, Dumas K, Litwin J, Phillips JJ, Waisfisz Q, Weiss MM, Hendriks Y, Stuurman KE, Nelson SF, Grody WW, Lee H, Kwok PY, Shieh JT. Missense-depleted regions in population exomes implicate ras superfamily nucleotide-binding protein alteration in patients with brain malformation. NPJ Genom Med. 2016; 1. PMID: 28868155.
      View in: PubMed
    17. Grody WW. Where to Draw the Boundaries for Prenatal Carrier Screening. JAMA. 2016 Aug 16; 316(7):717-9. PMID: 27533155.
      View in: PubMed
    18. Grody WW. The next generation of cancer management. Cancer Biol Med. 2016 Mar; 13(1):1-2. PMID: 27144057; PMCID: PMC4850118.
    19. Mooney KL, Choy W, Woodard J, Xian RR, Deal TM, Kendle RF, Said J, Grody W, Yang I. Primary central nervous system gamma delta cytotoxic T-cell lymphoma. J Clin Neurosci. 2016 Apr; 26:138-40. PMID: 26804925.
      View in: PubMed
    20. Deignan JL, Grody WW. Molecular Diagnosis of Cystic Fibrosis. Curr Protoc Hum Genet. 2016 Jan 01; 88:Unit 9.28. PMID: 26724724.
      View in: PubMed
    21. Kansal R, Li X, Shen J, Samuel D, Laningham F, Lee H, Panigrahi GB, Shuen A, Kantarci S, Dorrani N, Reiss J, Shintaku P, Deignan JL, Strom SP, Pearson CE, Vilain E, Grody WW. An infant with MLH3 variants, FOXG1-duplication and multiple, benign cranial and spinal tumors: A clinical exome sequencing study. Genes Chromosomes Cancer. 2016 Feb; 55(2):131-42. PMID: 26542077.
      View in: PubMed
    22. Ji J, Lee H, Argiropoulos B, Dorrani N, Mann J, Martinez-Agosto JA, Gomez-Ospina N, Gallant N, Bernstein JA, Hudgins L, Slattery L, Isidor B, Le Caignec C, David A, Obersztyn E, Wisniowiecka-Kowalnik B, Fox M, Deignan JL, Vilain E, Hendricks E, Horton Harr M, Noon SE, Jackson JR, Wilkens A, Mirzaa G, Salamon N, Abramson J, Zackai EH, Krantz I, Innes AM, Nelson SF, Grody WW, Quintero-Rivera F. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies. Eur J Hum Genet. 2015 Nov; 23(11):1473-81. PMID: 25944381; PMCID: PMC4613469 [Available on 10/01/16].
    23. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015 May; 17(5):405-24. PMID: 25741868; PMCID: PMC4544753.
    24. Cherukuri DP, Deignan JL, Das K, Grody WW, Herschman H. Instability of a dinucleotide repeat in the 3'-untranslated region (UTR) of the microsomal prostaglandin E synthase-1 (mPGES-1) gene in microsatellite instability-high (MSI-H) colorectal carcinoma. Mol Oncol. 2015 Aug; 9(7):1252-8. PMID: 25817443; PMCID: PMC4523444.
    25. Arboleda VA, Lee H, Dorrani N, Zadeh N, Willis M, Macmurdo CF, Manning MA, Kwan A, Hudgins L, Barthelemy F, Miceli MC, Quintero-Rivera F, Kantarci S, Strom SP, Deignan JL, Grody WW, Vilain E, Nelson SF. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. Am J Hum Genet. 2015 Mar 05; 96(3):498-506. PMID: 25728775; PMCID: PMC4375619.
    26. Lee H, Deignan JL, Dorrani N, Strom SP, Kantarci S, Quintero-Rivera F, Das K, Toy T, Harry B, Yourshaw M, Fox M, Fogel BL, Martinez-Agosto JA, Wong DA, Chang VY, Shieh PB, Palmer CG, Dipple KM, Grody WW, Vilain E, Nelson SF. Clinical exome sequencing for genetic identification of rare Mendelian disorders. JAMA. 2014 Nov 12; 312(18):1880-7. PMID: 25326637; PMCID: PMC4278636.
    27. Fogel BL, Lee H, Deignan JL, Strom SP, Kantarci S, Wang X, Quintero-Rivera F, Vilain E, Grody WW, Perlman S, Geschwind DH, Nelson SF. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol. 2014 Oct; 71(10):1237-46. PMID: 25133958; PMCID: PMC4324730.
    28. Aziz N, Zhao Q, Bry L, Driscoll DK, Funke B, Gibson JS, Grody WW, Hegde MR, Hoeltge GA, Leonard DG, Merker JD, Nagarajan R, Palicki LA, Robetorye RS, Schrijver I, Weck KE, Voelkerding KV. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests. Arch Pathol Lab Med. 2015 Apr; 139(4):481-93. PMID: 25152313.
      View in: PubMed
    29. Grody WW, Vilain E, Nelson SF. Interpreting whole-genome sequencing. JAMA. 2014 Jul 16; 312(3):296. PMID: 25027151.
      View in: PubMed
    30. Hu C, Kasten J, Park H, Bhargava R, Tai DS, Grody WW, Nguyen QG, Hauschka SD, Cederbaum SD, Lipshutz GS. Myocyte-mediated arginase expression controls hyperargininemia but not hyperammonemia in arginase-deficient mice. Mol Ther. 2014 Oct; 22(10):1792-802. PMID: 24888478; PMCID: PMC4428413.
    31. Strom SP, Lozano R, Lee H, Dorrani N, Mann J, O'Lague PF, Mans N, Deignan JL, Vilain E, Nelson SF, Grody WW, Quintero-Rivera F. De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing. BMC Med Genet. 2014 May 01; 15:49. PMID: 24886118; PMCID: PMC4072606.
    32. Loh JC, Cassarino DS, Grody WW, Chiu MW, Pinter-Brown LC. A case of mycosis fungoides transmitted from donor to recipient, and review of literature of T-cell malignancies after transplantation. Clin Lymphoma Myeloma Leuk. 2014 Aug; 14(4):e137-40. PMID: 24637131.
      View in: PubMed
    33. Strom SP, Lee H, Das K, Vilain E, Nelson SF, Grody WW, Deignan JL. Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory. Genet Med. 2014 Jul; 16(7):510-5. PMID: 24406459; PMCID: PMC4079763.
    34. Grody WW, Thompson BH, Hudgins L. Whole-exome/genome sequencing and genomics. Pediatrics. 2013 Dec; 132(Suppl 3):S211-5. PMID: 24298129.
      View in: PubMed
    35. Massie J, Castellani C, Grody WW. Carrier screening for cystic fibrosis in the new era of medications that restore CFTR function. Lancet. 2014 Mar 08; 383(9920):923-5. PMID: 23992917.
      View in: PubMed
    36. Kasten J, Hu C, Bhargava R, Park H, Tai D, Byrne JA, Marescau B, De Deyn PP, Schlichting L, Grody WW, Cederbaum SD, Lipshutz GS. Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse. Mol Genet Metab. 2013 Nov; 110(3):222-30. PMID: 23920045; PMCID: PMC3800271.
    37. Kalman LV, Lubin IM, Barker S, du Sart D, Elles R, Grody WW, Pazzagli M, Richards S, Schrijver I, Zehnbauer B. Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics. Arch Pathol Lab Med. 2013 Jul; 137(7):983-8. PMID: 23808472; PMCID: PMC4684176.
    38. Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, McGuire AL, Nussbaum RL, O'Daniel JM, Ormond KE, Rehm HL, Watson MS, Williams MS, Biesecker LG. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013 Jul; 15(7):565-74. PMID: 23788249.
      View in: PubMed
    39. Grody WW, Thompson BH, Gregg AR, Bean LH, Monaghan KG, Schneider A, Lebo RV. ACMG position statement on prenatal/preconception expanded carrier screening. Genet Med. 2013 Jun; 15(6):482-3. PMID: 23619275.
      View in: PubMed
    40. Palmer CG, Boudreault P, Baldwin EE, Fox M, Deignan JL, Kobayashi Y, Sininger Y, Grody W, Sinsheimer JS. Deaf genetic testing and psychological well-being in deaf adults. J Genet Couns. 2013 Aug; 22(4):492-507. PMID: 23430402; PMCID: PMC3701749.
    41. Bavisetty S, Grody WW, Yazdani S. Emergence of pediatric rare diseases: Review of present policies and opportunities for improvement. Rare Dis. 2013; 1:e23579. PMID: 25002987; PMCID: PMC3932940.
    42. Ong FS, Kuo JZ, Wu WC, Cheng CY, Blackwell WL, Taylor BL, Grody WW, Rotter JI, Lai CC, Wong TY. Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization. J Pers Med. 2013; 3(1):40-69. PMID: 24624293.
      View in: PubMed
    43. Schrijver I, Aziz N, Farkas DH, Furtado M, Gonzalez AF, Greiner TC, Grody WW, Hambuch T, Kalman L, Kant JA, Klein RD, Leonard DG, Lubin IM, Mao R, Nagan N, Pratt VM, Sobel ME, Voelkerding KV, Gibson JS. Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. J Mol Diagn. 2012 Nov; 14(6):525-40. PMID: 22918138.
      View in: PubMed
    44. Patrinos GP, Smith TD, Howard H, Al-Mulla F, Chouchane L, Hadjisavvas A, Hamed SA, Li XT, Marafie M, Ramesar RS, Ramos FJ, de Ravel T, El-Ruby MO, Shrestha TR, Sobrido MJ, Tadmouri G, Witsch-Baumgartner M, Zilfalil BA, Auerbach AD, Carpenter K, Cutting GR, Dung VC, Grody W, Hasler J, Jorde L, Kaput J, Macek M, Matsubara Y, Padilla C, Robinson H, Rojas-Martinez A, Taylor GR, Vihinen M, Weber T, Burn J, Qi M, Cotton RG, Rimoin D. Human Variome Project country nodes: documenting genetic information within a country. Hum Mutat. 2012 Nov; 33(11):1513-9. PMID: 22753370.
      View in: PubMed
    45. Lee EK, Hu C, Bhargava R, Rozengurt N, Stout D, Grody WW, Cederbaum SD, Lipshutz GS. Long-term survival of the juvenile lethal arginase-deficient mouse with AAV gene therapy. Mol Ther. 2012 Oct; 20(10):1844-51. PMID: 22760543; PMCID: PMC3464644.
    46. Ong FS, Das K, Wang J, Vakil H, Kuo JZ, Blackwell WL, Lim SW, Goodarzi MO, Bernstein KE, Rotter JI, Grody WW. Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing. Expert Rev Mol Diagn. 2012 Jul; 12(6):593-602. PMID: 22845480; PMCID: PMC3495985.
    47. Green RC, Berg JS, Berry GT, Biesecker LG, Dimmock DP, Evans JP, Grody WW, Hegde MR, Kalia S, Korf BR, Krantz I, McGuire AL, Miller DT, Murray MF, Nussbaum RL, Plon SE, Rehm HL, Jacob HJ. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med. 2012 Apr; 14(4):405-10. PMID: 22422049; PMCID: PMC3763716.
    48. Ong FS, Deignan JL, Kuo JZ, Bernstein KE, Rotter JI, Grody WW, Das K. Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation. Pharmacogenomics. 2012 Mar; 13(4):465-75. PMID: 22380001; PMCID: PMC3306231.
    49. Dry S, Grody WW, Papagni P. Stuck between a scalpel and a rock, or molecular pathology and legal-ethical issues in use of tissues for clinical care and research: what must a pathologist know? Am J Clin Pathol. 2012 Mar; 137(3):346-55. PMID: 22338046.
      View in: PubMed
    50. Palomaki GE, Deciu C, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Grody WW, Nelson SF, Canick JA. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med. 2012 Mar; 14(3):296-305. PMID: 22281937; PMCID: PMC3938175.
    51. Grody WW. Expanded carrier screening and the law of unintended consequences: from cystic fibrosis to fragile X. Genet Med. 2011 Dec; 13(12):996-7. PMID: 22134443.
      View in: PubMed
    52. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med. 2011 Nov; 13(11):913-20. PMID: 22005709.
      View in: PubMed
    53. Ong FS, Grody WW, Deignan JL. Privacy and data management in the era of massively parallel next-generation sequencing. Expert Rev Mol Diagn. 2011 Jun; 11(5):457-9. PMID: 21707452; PMCID: PMC3130532.
    54. Zadeh N, Getzug T, Grody WW. Diagnosis and management of familial Mediterranean fever: integrating medical genetics in a dedicated interdisciplinary clinic. Genet Med. 2011 Mar; 13(3):263-9. PMID: 21317656.
      View in: PubMed
    55. Deignan JL, Grody WW. Ordering genetic tests and interpreting the results. Adv Otorhinolaryngol. 2011; 70:18-24. PMID: 21358180.
      View in: PubMed
    56. Grody WW, Getzug T. Colchicine's other indication--effect of FDA action. N Engl J Med. 2010 Dec 02; 363(23):2267-8. PMID: 21121853.
      View in: PubMed
    57. Quintero-Rivera F, Deignan JL, Peredo J, Grody WW, Crandall B, Sims M, Cederbaum SD. An exon 1 deletion in OTC identified using chromosomal microarray analysis in a mother and her two affected deceased newborns: implications for the prenatal diagnosis of ornithine transcarbamylase deficiency. Mol Genet Metab. 2010 Dec; 101(4):413-6. PMID: 20817516.
      View in: PubMed
    58. Bender L, Silverman LM, Dinulos MB, Nickel J, Grody WW. Direct-to-consumer genotyping: are we ready for a brave new world? Clin Chem. 2010 Jul; 56(7):1056-60. PMID: 20511451.
      View in: PubMed
    59. Wehling-Henricks M, Jordan MC, Gotoh T, Grody WW, Roos KP, Tidball JG. Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy. PLoS One. 2010 May 21; 5(5):e10763. PMID: 20505827; PMCID: PMC2874011.
    60. Boudreault P, Baldwin EE, Fox M, Dutton L, Tullis L, Linden J, Kobayashi Y, Zhou J, Sinsheimer JS, Sininger Y, Grody WW, Palmer CG. Deaf adults' reasons for genetic testing depend on cultural affiliation: results from a prospective, longitudinal genetic counseling and testing study. J Deaf Stud Deaf Educ. 2010; 15(3):209-27. PMID: 20488870; PMCID: PMC2902357.
    61. Castellani C, Macek M, Cassiman JJ, Duff A, Massie J, ten Kate LP, Barton D, Cutting G, Dallapiccola B, Dequeker E, Girodon E, Grody W, Highsmith EW, Kääriäinen H, Kruip S, Morris M, Pignatti PF, Pypops U, Schwarz M, Soller M, Stuhrman M, Cuppens H. Benchmarks for cystic fibrosis carrier screening: a European consensus document. J Cyst Fibros. 2010 May; 9(3):165-78. PMID: 20363197.
      View in: PubMed
    62. Grody WW, Howell RR. The fate of newborn screening blood spots. Pediatr Res. 2010 Mar; 67(3):237. PMID: 20154576.
      View in: PubMed
    63. Grody WW. Genetics in Hollywood: from real to reel. Clin Genet. 2010 Feb; 77(2):106-11. PMID: 20096067.
      View in: PubMed
    64. Barker SD, Bale S, Booker J, Buller A, Das S, Friedman K, Godwin AK, Grody WW, Highsmith E, Kant JA, Lyon E, Mao R, Monaghan KG, Payne DA, Pratt VM, Schrijver I, Shrimpton AE, Spector E, Telatar M, Toji L, Weck K, Zehnbauer B, Kalman LV. Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing. J Mol Diagn. 2009 Nov; 11(6):553-61. PMID: 19767587; PMCID: PMC2765754.
    65. Rosove MH, Grody WW. Should we be applying warfarin pharmacogenetics to clinical practice? No, not now. Ann Intern Med. 2009 Aug 18; 151(4):270-3, W95. PMID: 19687493.
      View in: PubMed
    66. Palmer CG, Martinez A, Fox M, Zhou J, Shapiro N, Sininger Y, Grody WW, Schimmenti LA. A prospective, longitudinal study of the impact of GJB2/GJB6 genetic testing on the beliefs and attitudes of parents of deaf and hard-of-hearing infants. Am J Med Genet A. 2009 Jun; 149A(6):1169-82. PMID: 19449415; PMCID: PMC2866144.
    67. Gau CL, Rosenblatt RA, Cerullo V, Lay FD, Dow AC, Livesay J, Brunetti-Pierri N, Lee B, Cederbaum SD, Grody WW, Lipshutz GS. Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector. Mol Ther. 2009 Jul; 17(7):1155-63. PMID: 19367256; PMCID: PMC2835205.
    68. Grody WW. Cystic fibrosis testing comes of age. J Mol Diagn. 2009 May; 11(3):173-5. PMID: 19359497; PMCID: PMC2671332.
    69. Pullarkat ST, Pullarkat V, Kroft SH, Wilson CS, Ahsanuddin AN, Mann KP, Thein M, Grody WW, Brynes RK. Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia. J Hematop. 2009 Mar; 2(1):27-33. PMID: 19669220; PMCID: PMC2713498.
    70. ten Bosch JR, Grody WW. Keeping up with the next generation: massively parallel sequencing in clinical diagnostics. J Mol Diagn. 2008 Nov; 10(6):484-92. PMID: 18832462; PMCID: PMC2570630.
    71. Mumenthaler SM, Rozengurt N, Livesay JC, Sabaghian A, Cederbaum SD, Grody WW. Disruption of arginase II alters prostate tumor formation in TRAMP mice. Prostate. 2008 Oct 01; 68(14):1561-9. PMID: 18663728.
      View in: PubMed
    72. Schimmenti LA, Martinez A, Telatar M, Lai CH, Shapiro N, Fox M, Warman B, McCarra M, Crandall B, Sininger Y, Grody WW, Palmer CG. Infant hearing loss and connexin testing in a diverse population. Genet Med. 2008 Jul; 10(7):517-24. PMID: 18580690.
      View in: PubMed
    73. Grody WW, Richards CS. New quality assurance standards for rare disease testing. Genet Med. 2008 May; 10(5):320-4. PMID: 18496029.
      View in: PubMed
    74. Richards CS, Bale S, Bellissimo DB, Das S, Grody WW, Hegde MR, Lyon E, Ward BE. ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genet Med. 2008 Apr; 10(4):294-300. PMID: 18414213.
      View in: PubMed
    75. Mumenthaler SM, Yu H, Tze S, Cederbaum SD, Pegg AE, Seligson DB, Grody WW. Expression of arginase II in prostate cancer. Int J Oncol. 2008 Feb; 32(2):357-65. PMID: 18202758.
      View in: PubMed
    76. Deignan JL, Marescau B, Livesay JC, Iyer RK, De Deyn PP, Cederbaum SD, Grody WW. Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia. Mol Genet Metab. 2008 Feb; 93(2):172-8. PMID: 17997338.
      View in: PubMed
    77. Grody WW, Cutting GR, Watson MS. The Cystic Fibrosis mutation "arms race": when less is more. Genet Med. 2007 Nov; 9(11):739-44. PMID: 18007142.
      View in: PubMed
    78. Deignan JL, Cederbaum SD, Grody WW. Contrasting features of urea cycle disorders in human patients and knockout mouse models. Mol Genet Metab. 2008 Jan; 93(1):7-14. PMID: 17933574; PMCID: PMC2692509.
    79. Palmer CG, Martinez A, Fox M, Sininger Y, Grody WW, Schimmenti LA. Ethnic differences in parental perceptions of genetic testing for deaf infants. J Genet Couns. 2008 Feb; 17(1):129-38. PMID: 17952575.
      View in: PubMed
    80. Deignan JL, Livesay JC, Shantz LM, Pegg AE, O'Brien WE, Iyer RK, Cederbaum SD, Grody WW. Polyamine homeostasis in arginase knockout mice. Am J Physiol Cell Physiol. 2007 Oct; 293(4):C1296-301. PMID: 17686999.
      View in: PubMed
    81. Blase T, Martinez A, Grody WW, Schimmenti L, Palmer CG. Sharing GJB2/GJB6 genetic test information with family members. J Genet Couns. 2007 Jun; 16(3):313-24. PMID: 17318457.
      View in: PubMed
    82. Lebo RV, Grody WW. Testing and reporting ACMG cystic fibrosis mutation panel results. Genet Test. 2007; 11(1):11-31. PMID: 17394390.
      View in: PubMed
    83. Lebo RV, Grody WW. Variable penetrance and expressivity of the splice altering 5T sequence in the cystic fibrosis gene. Genet Test. 2007; 11(1):32-44. PMID: 17394391.
      View in: PubMed
    84. Elshimali YI, Grody WW. The clinical significance of circulating tumor cells in the peripheral blood. Diagn Mol Pathol. 2006 Dec; 15(4):187-94. PMID: 17122646.
      View in: PubMed
    85. Deignan JL, Livesay JC, Yoo PK, Goodman SI, O'Brien WE, Iyer RK, Cederbaum SD, Grody WW. Ornithine deficiency in the arginase double knockout mouse. Mol Genet Metab. 2006 Sep-Oct; 89(1-2):87-96. PMID: 16753325.
      View in: PubMed
    86. Keen-Kim D, Grody WW, Richards CS. Microelectronic array system for molecular diagnostic genotyping: Nanogen NanoChip 400 and molecular biology workstation. Expert Rev Mol Diagn. 2006 May; 6(3):287-94. PMID: 16706733.
      View in: PubMed
    87. Ramsden SC, Deans Z, Robinson DO, Mountford R, Sistermans EA, Grody WW, McQuaid S, Patton SJ, Stenhouse SA. Monitoring standards for molecular genetic testing in the United Kingdom, the Netherlands, and Ireland. Genet Test. 2006; 10(3):147-56. PMID: 17020464.
      View in: PubMed
    88. Palmer CG, Martinez A, Sininger Y, Shapiro N, Grody WW, Schimmenti LA. Prelingual siblings of children with GJB2 hearing loss: issues to consider. Arch Otolaryngol Head Neck Surg. 2005 Nov; 131(11):1020-2. PMID: 16301377.
      View in: PubMed
    89. Chen B, O' Connell CD, Boone DJ, Amos JA, Beck JC, Chan MM, Farkas DH, Lebo RV, Richards CS, Roa BB, Silverman LM, Barton DE, Bejjani BA, Belloni DR, Bernacki SH, Caggana M, Charache P, Dequeker E, Ferreira-Gonzalez A, Friedman KJ, Greene CL, Grody WW, Highsmith WE, Hinkel CS, Kalman LV, Lubin IM, Lyon E, Payne DA, Pratt VM, Rohlfs E, Rundell CA, Schneider E, Willey AM, Williams LO, Willey JC, Winn-Deen ES, Wolff DJ. Developing a sustainable process to provide quality control materials for genetic testing. Genet Med. 2005 Oct; 7(8):534-49. PMID: 16247292.
      View in: PubMed
    90. Maddalena A, Bale S, Das S, Grody W, Richards S. Technical standards and guidelines: molecular genetic testing for ultra-rare disorders. Genet Med. 2005 Oct; 7(8):571-83. PMID: 16247296.
      View in: PubMed
    91. Spector EB, Grody WW, Matteson CJ, Palomaki GE, Bellissimo DB, Wolff DJ, Bradley LA, Prior TW, Feldman G, Popovich BW, Watson MS, Richards CS. Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories. Genet Med. 2005 Jul-Aug; 7(6):444-53. PMID: 16024978.
      View in: PubMed
    92. Jarvis M, Iyer RK, Williams LO, Noll WW, Thomas K, Telatar M, Grody WW. A novel method for creating artificial mutant samples for performance evaluation and quality control in clinical molecular genetics. J Mol Diagn. 2005 May; 7(2):247-51. PMID: 15858148; PMCID: PMC1867527.
    93. Ogino S, Flodman P, Wilson RB, Gold B, Grody WW. Risk calculations for cystic fibrosis in neonatal screening by immunoreactive trypsinogen and CFTR mutation tests. Genet Med. 2005 May-Jun; 7(5):317-27. PMID: 15915083.
      View in: PubMed
    94. Schimmenti LA, Martinez A, Fox M, Crandall B, Shapiro N, Telatar M, Sininger Y, Grody WW, Palmer CG. Genetic testing as part of the early hearing detection and intervention (EHDI) process. Genet Med. 2004 Nov-Dec; 6(6):521-5. PMID: 15545749.
      View in: PubMed
    95. Ogino S, Wilson RB, Gold B, Hawley P, Grody WW. Bayesian analysis for cystic fibrosis risks in prenatal and carrier screening. Genet Med. 2004 Sep-Oct; 6(5):439-49. PMID: 15371910.
      View in: PubMed
    96. Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, Palomaki GE, Popovich BW, Pratt VM, Rohlfs EM, Strom CM, Richards CS, Witt DR, Grody WW. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med. 2004 Sep-Oct; 6(5):387-91. PMID: 15371902; PMCID: PMC3110945.
    97. Tsongalis GJ, Belloni DR, Grody WW. Cystic fibrosis mutation analysis: how many is enough? Genet Med. 2004 Sep-Oct; 6(5):456-8. PMID: 15371913.
      View in: PubMed
    98. Cederbaum SD, Yu H, Grody WW, Kern RM, Yoo P, Iyer RK. Arginases I and II: do their functions overlap? Mol Genet Metab. 2004 Apr; 81 Suppl 1:S38-44. PMID: 15050972.
      View in: PubMed
    99. Richards CS, Grody WW. Prenatal screening for cystic fibrosis: past, present and future. Expert Rev Mol Diagn. 2004 Jan; 4(1):49-62. PMID: 14711349.
      View in: PubMed
    100. Palomaki GE, Haddow JE, Bradley LA, Richards CS, Stenzel TT, Grody WW. Estimated analytic validity of HFE C282Y mutation testing in population screening: the potential value of confirmatory testing. Genet Med. 2003 Nov-Dec; 5(6):440-3. PMID: 14614395.
      View in: PubMed
    101. Grody WW. Quest for controls in molecular genetics. J Mol Diagn. 2003 Nov; 5(4):209-11. PMID: 14573778; PMCID: PMC1907341.
    102. Yu H, Yoo PK, Aguirre CC, Tsoa RW, Kern RM, Grody WW, Cederbaum SD, Iyer RK. Widespread expression of arginase I in mouse tissues. Biochemical and physiological implications. J Histochem Cytochem. 2003 Sep; 51(9):1151-60. PMID: 12923240.
      View in: PubMed
    103. Richards CS, Grody WW. Alternative approaches to proficiency testing in molecular genetics. Clin Chem. 2003 May; 49(5):717-8. PMID: 12709360.
      View in: PubMed
    104. Venegas PB, Novak JM, Oscar CA, Sánchez FL, Gutiérrez IG, Rivera JM, Salas JP, Montero JF, Grody WW. Cystic fibrosis mutations in Costa Rica. Hum Biol. 2003 Apr; 75(2):179-88. PMID: 12943157.
      View in: PubMed
    105. Grody WW. Ethical issues raised by genetic testing with oligonucleotide microarrays. Mol Biotechnol. 2003 Feb; 23(2):127-38. PMID: 12632697.
      View in: PubMed
    106. Watson MS, Desnick RJ, Grody WW, Mennuti MT, Popovich BW, Richards CS. Cystic fibrosis carrier screening: issues in implementation. Genet Med. 2002 Nov-Dec; 4(6):407-9. PMID: 12509709.
      View in: PubMed
    107. Richards CS, Bradley LA, Amos J, Allitto B, Grody WW, Maddalena A, McGinnis MJ, Prior TW, Popovich BW, Watson MS, Palomaki GE. Standards and guidelines for CFTR mutation testing. Genet Med. 2002 Sep-Oct; 4(5):379-91. PMID: 12394352.
      View in: PubMed
    108. Emmanouilides C, Lill M, Telatar M, Rosenfelt F, Grody W, Territo M, Rosen P. Mitoxantrone/ifosfamide/etoposide salvage regimen with rituximab for in vivo purging in patients with relapsed lymphoma. Clin Lymphoma. 2002 Sep; 3(2):111-6. PMID: 12435284.
      View in: PubMed
    109. Sharma P, Rosenbaum AL, Vives T, Grody WW, Demer JL. Discordant pursuit asymmetry and esotropia in monozygous twins. Am J Ophthalmol. 2002 Jul; 134(1):143-6. PMID: 12095832.
      View in: PubMed
    110. Yu H, Iyer RK, Yoo PK, Kern RM, Grody WW, Cederbaum SD. Arginase expression in mouse embryonic development. Mech Dev. 2002 Jul; 115(1-2):151-5. PMID: 12049781.
      View in: PubMed
    111. Iyer RK, Yoo PK, Kern RM, Rozengurt N, Tsoa R, O'Brien WE, Yu H, Grody WW, Cederbaum SD. Mouse model for human arginase deficiency. Mol Cell Biol. 2002 Jul; 22(13):4491-8. PMID: 12052859; PMCID: PMC133904.
    112. Huang TJ, Liu M, Knight LD, Grody WW, Miller JF, Ho CM. An electrochemical detection scheme for identification of single nucleotide polymorphisms using hairpin-forming probes. Nucleic Acids Res. 2002 Jun 15; 30(12):e55. PMID: 12060693; PMCID: PMC117297.
    113. Kim PS, Iyer RK, Lu KV, Yu H, Karimi A, Kern RM, Tai DK, Cederbaum SD, Grody WW. Expression of the liver form of arginase in erythrocytes. Mol Genet Metab. 2002 Jun; 76(2):100-10. PMID: 12083807.
      View in: PubMed
    114. Iyer RK, Kim HK, Tsoa RW, Grody WW, Cederbaum SD. Cloning and characterization of human agmatinase. Mol Genet Metab. 2002 Mar; 75(3):209-18. PMID: 11914032.
      View in: PubMed
    115. Grody WW. Molecular genetic risk screening. Annu Rev Med. 2003; 54:473-90. PMID: 12525682.
      View in: PubMed